CD8A and neoplasm: Furthermore, we show that the co-expression of CD8α in CD4+ TEG011 provides additional survival signal and facilitates better T-cell persistence and infiltration in vivo, both of which are essential to sustain long-term tumor control of adoptively transferred TCR-based immunotherapy.